News
RMD
237.27
+2.46%
5.69
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025
NASDAQ · 1d ago
ResMed Inc.'s (NYSE:RMD) institutional investors lost 4.5% last week but have benefitted from longer-term gains
Simply Wall St · 1d ago
YieldBoost ResMed From 0.9% To 6.8% Using Options
NASDAQ · 3d ago
BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing
NASDAQ · 3d ago
NEOG Stock Gains From New Addition to the Petrifilm Product Line
NASDAQ · 3d ago
SNN Stock Might Rise Following FDA Nod for AETOS Stemless
NASDAQ · 4d ago
Pioneer Select Mid Cap Growth Fund Q3 2024 Performance And Market Commentary
Seeking Alpha · 5d ago
ZBH Stock Might Rise Following FDA Nod for OsseoFit
NASDAQ · 5d ago
Weekly Report: what happened at RMD last week (1209-1213)?
Weekly Report · 5d ago
How Is West Pharmaceutical Services' Stock Performance Compared to Other Medical Devices Stocks?
Barchart · 6d ago
This AutoZone Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Benzinga · 12/13 14:58
QIAGEN Stock Gains Following the Latest Launch of IPA Interpret
NASDAQ · 12/13 13:04
ResMed Initiated at Hold by Stifel
Dow Jones · 12/13 09:44
ResMed Price Target Announced at $250.00/Share by Stifel
Dow Jones · 12/13 09:44
Stifel Initiates Coverage On ResMed with Hold Rating, Announces Price Target of $250
Benzinga · 12/13 09:33
Zacks.com featured highlights include InterDigital, ResMed, Greenbrier Companies, Charles River Associates and Kontoor Brands
NASDAQ · 12/13 07:15
ResMed initiated with a Hold at Stifel
TipRanks · 12/12 21:16
ResMed launches head strap for Apple's Vision Pro system
Seeking Alpha · 12/12 20:57
RMD or PODD: Which Is the Better Value Stock Right Now?
NASDAQ · 12/12 16:40
5 Solid Dividend Growth Stocks to Buy Now
NASDAQ · 12/12 14:11
More
Webull provides a variety of real-time RMD stock news. You can receive the latest news about Resmed through multiple platforms. This information may help you make smarter investment decisions.
About RMD
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. The Company’s segments include Sleep and Respiratory Care and SaaS. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care to improve patient outcomes.